Drug development
The company is developing drugs intended to bring medicines to patients.
Source: LinkedIn company description · Retrieved October 13, 2026
Amphista Therapeutics is developing drugs.
Targeted protein degradation modulates the abundance of proteins responsible for disease progression by using the cell’s degradation machinery. The company’s protein degradation approach differs from traditional targeted protein degradation technologies and is being developed to treat diseases with high unmet need.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company is developing drugs intended to bring medicines to patients.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 15, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026 and October 7, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.